Navigation Links
Roche's Investigational Polymerase Inhibitor, Combined with PEGASYS(R) and COPEGUS(TM), Shows Potent Antiviral Activity in Treatment of Chronic Hepatitis C at Four Weeks
Date:11/2/2007

atment. PEGASYS is also contraindicated in hepatic decompensation with Child-Pugh score greater than or equal to 6 in cirrhotic CHC patients coinfected with HIV before or during treatment. PEGASYS is also contraindicated in neonates and infants because it contains benzyl alcohol. Benzyl alcohol is associated with an increased incidence of neurological and other complications in neonates and infants, which are sometimes fatal. PEGASYS and COPEGUS therapy is additionally contraindicated in patients with a hypersensitivity to COPEGUS or any of its components, in women who are pregnant, men whose female partners are pregnant, and patients with hemoglobinopathies (eg, thalassemia major, sickle-cell anemia).

COPEGUS THERAPY SHOULD NOT BE STARTED UNLESS A REPORT OF A NEGATIVE PREGNANCY TEST HAS BEEN OBTAINED IMMEDIATELY PRIOR TO INITIATION OF THERAPY. Women of childbearing potential and men must use two forms of effective contraception during treatment and during the 6 months after treatment has concluded. Routine monthly pregnancy tests must be performed during this time. If pregnancy should occur during treatment or during 6 months post-therapy, the patient must be advised of the significant teratogenic risk of COPEGUS therapy to the fetus. Healthcare providers and patients are strongly encouraged to immediately report any pregnancy in a patient or partner of a patient during treatment or during 6 months after treatment cessation to the Ribavirin Pregnancy Registry at 1-800-593-2214.

Chronic hepatitis C (CHC) patients with cirrhosis may be at risk of hepatic decompensation and death when treated with alpha interferons, including PEGASYS. During treatment, patients' clinical status and hepatic function should be closely monitored, and PEGASYS treatment should be immediately discontinued if decompensation (Child-Pugh score greater than or equal to 6) is observed.

The most common adverse events reported for PEGASYS and COPEGUS combination therapy observed
'/>"/>

SOURCE Roche
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Phase 3 Results for Dabigatran Etexilate, an Investigational Oral Anticoagulant, Presented Today at the XXIst Congress of the International Society on Thrombosis and Haemostasis
2. An Investigational Study Released at ADA Showed that Initial Combination Therapy with Januvia (sitagliptin) and Metformin Led to Improvement in Markers of Beta Cell Function in Patients with Type 2 Diabetes
3. Late Breaking Data Released at ADA Showed that the Investigational Use of Januvia and Metformin as Initial Combination Therapy Provided Significant Glucose Lowering Efficacy over 54 Weeks in Patients with Type 2 Diabetes
4. Investigational Study Demonstrated a Re-Establishment of Clinical Improvement with Orencia (Abatacept) in Children with Juvenile Idiopathic Arthritis upon Re-Introduction of Therapy
5. Mercks Investigational Migraine Treatment MK-0974 Significantly Improved Migraine Pain on Several Efficacy Measures in a Phase II Study
6. Data Demonstrated Metastatic Melanoma Response to Investigational Immunotherapy Ipilimumab
7. Investigational Drug Cediranib (AZD2171) Shows Promise in Patients With Recurrent Glioblastoma (GBM)
8. Additional New Data from Satraplatin SPARC Phase 3 Investigational Trial Presented at ASCO Annual Meeting
9. Additional New Data from Satraplatin SPARC Phase 3 Investigational Trial Presented at ASCO Annual Meeting
10. Investigational Cancer Drug Pertuzumab Shows Promising Results in Advanced Breast Cancer When Combined with Herceptin
11. Shire Announces Positive Results of Studies With Guanfacine Extended Release, An Investigational Nonstimulant Medication Filed for the Treatment of ADHD in Children and Adolescents
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/6/2015)... 6, 2015  OrthoSpace Ltd. ("OrthoSpace" or "Company") ... patients in its US Investigational Device Exemption (IDE) ... randomized, single blinded control study that compares the ... or partial repair for the treatment of full ... currently commercially available outside of the ...
(Date:7/6/2015)... HORSHAM, Pa. , July 6, 2015 /PRNewswire/ ... procedure-based, bone fixation concept the FlowerCube™, announced today ... approval opens the opportunity for significant expansion of ...   The approval encompasses Flower Orthopedics, ... fixation solutions for upper and lower extremities. Consisting ...
(Date:7/6/2015)... 6, 2015 Increase in ... bioinformatics market in Germany through ... TechSci Research report, " Germany Bioinformatics Market Forecast & ... is projected to register a CAGR of ... witness tremendous growth on account of rising government funding ...
Breaking Medicine Technology:OrthoSpace Enrolls First Patients in US IDE Study 2Flower Orthopedics cleared to enter the European Union 2Germany Bioinformatics Market to Grow at a CAGR Over 29% Through 2020 Says TechSci Research 2Germany Bioinformatics Market to Grow at a CAGR Over 29% Through 2020 Says TechSci Research 3
... The Joint Commission has awarded Sutter Medical Center, ... the Sacramento region,s only heart transplant program to ... therapy and not just as bridges to transplant. ... hospital in Northern California to have this certification. ...
... Mich., Nov. 10 Stryker Corporation (NYSE: SYK ... a privately held, software technology firm. OtisMed will focus ... complement the many benefits that surgeons and patients realize ... Stryker implants. OtisMed will operate as part of Stryker,s ...
Cached Medicine Technology:Sutter Medical Center Receives Certification to Use Ventricular Assist Devices as Destination Therapy 2Stryker Announces Agreements To Acquire Assets 2Stryker Announces Agreements To Acquire Assets 3
(Date:7/6/2015)... ... 2015 , ... Currently, mobile testing is one the fastest ... the molecular diagnostic technologies, wide availability of immunosuppressive drugs and bioterrorism threats are ... engineering also open lucrative opportunities for the market players. , However, there are ...
(Date:7/6/2015)... ... ... TapGlance ” was featured on NewsWatch as part of its monthly AppWatch, which takes ... and Windows. Joe Toohey, the host of AppWatch and technology expert, conducted the app ... rooms will look like before they even start renovating.. , Whether a person is ...
(Date:7/6/2015)... Hill, CA (PRWEB) , ... July 06, 2015 , ... ... Doctors on Liens , the leading network of doctors working on a lien basis. ... with Doctors on Liens. , The daughter of two Cambodian refugees, Dr. Lim suffered ...
(Date:7/6/2015)... ... July 06, 2015 , ... The Asian-Pacific market for rheumatoid arthritis therapeutics ... to grow at a CAGR of over 3.2 percent in the years to come ... to be mainly spurred by an anticipated launch of a number of promising pipeline ...
(Date:7/6/2015)... CA (PRWEB) , ... July 06, 2015 , ... ... disease prevention in southern California, has partnered with Woodbridge Walk-In Urgent Care to ... cancer, stroke and other serious medical conditions. Screenings are affordable and accurate and ...
Breaking Medicine News(10 mins):Health News:World Infectious Disease Testing Market Examined by VPGMarketResearch.com in In-Demand Report Available at MarketPublishers.com 2Health News:World Infectious Disease Testing Market Examined by VPGMarketResearch.com in In-Demand Report Available at MarketPublishers.com 3Health News:Create a Space with TapGlance, a Revolutionary Interior Design Application 2Health News:Respected Chiropractor Opens Office in Signal Hill/Cambodia Town and Joins Doctors on Liens 2Health News:APAC Rheumatoid Arthritis Therapeutics Market to Reach Value of USD 6.9 Billion by 2021, Says GBI Research in Its New Report Now Available at MarketPublishers.com 2Health News:Woodbridge Walk-In Offers Affordable Early Detection Health Screenings Through Longevity 2
... Each year Baltimore ... chosen by their fellow medical professionals. Baltimore rhinoplasty and facelift surgeon Dr. James ... compilation of the 2009 ‘Top Docs’ list. , ... Baltimore, MD (Vocus) Feb. 6, 2010 -- In its annual ‘Top Docs’ ...
... Popularity ... ... to apply to the first Doctor of Nursing Practice degree program offered in the state ... of Colleges and Schools, is administered by the Loyola University New Orleans School of Nursing ...
... , PHOENIX ... three new products to its Relivables line at the company,s ... of the Relivables line since it was introduced last August. ... Relivables snack bars "r" body revitalizing moisture plus ...
... , , SAN DIEGO , Feb. ... today that it has completed its previously announced offer to exchange ... million aggregate principal amount of 4.125% Senior Notes due 2012, ... due 2014, and $700 million aggregate principal amount of ...
... ... was first spotted at San Francisco,s famed PIER 39 docks, was successfully rescued, rehabilitated and ... rainy skies, a crowd assembled at Rodeo Beach in the Marin Headlands, Sausalito, CA to ... ...
... FRIDAY, Feb. 5 (HealthDay News) -- Minimally invasive laparoscopic ... surgeons, suggests a new survey. , University of Maryland ... laparoscopic surgeons who took part in the poll said ... a pending epidemic of occupational injuries to surgeons and ...
Cached Medicine News:Health News:Maryland Plastic Surgeon Dr. James Vogel Selected as Physician Advisor by Baltimore Magazine for Annual “Top Doc” Issue 2Health News:Maryland Plastic Surgeon Dr. James Vogel Selected as Physician Advisor by Baltimore Magazine for Annual “Top Doc” Issue 3Health News:Loyola's Doctor of Nursing Practice Application Deadline Extended 2Health News:Loyola's Doctor of Nursing Practice Application Deadline Extended 3Health News:Reliv International Expands Its Relivables Line 2Health News:Reliv International Expands Its Relivables Line 3Health News:CareFusion Announces Completion of Exchange Offer for 4.125% Senior Notes Due 2012, 5.125% Senior Notes Due 2014, and 6.375% Senior Notes Due 2019 2Health News:Entangled in Fishing Line then Rescued by The Marine Mammal Center - a Sea Lion Goes Back to the Ocean 2Health News:Entangled in Fishing Line then Rescued by The Marine Mammal Center - a Sea Lion Goes Back to the Ocean 3Health News:Entangled in Fishing Line then Rescued by The Marine Mammal Center - a Sea Lion Goes Back to the Ocean 4
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: